The research and development of new Chinese medicines is a manifestation of innovation in the field of Chinese medicine. The country has issued a number of policies to support the research and development of new Chinese medicines.

However, the launch of new drugs requires clear pharmacological effects and standardized clinical verification, which are different from the traditional empirical verification of Chinese medicine. Enterprises need to clarify the composition of new Chinese medicines and conduct targeted pharmacological experiments.

At present, the research and development of new Chinese medicines is challenging, but the application of digital technology can solve these problems. At the same time, through data sharing, it also improves the efficiency and success rate of research and development of new Chinese medicines.

In the eleventh point of the "Opinions", it is also specifically mentioned to promote the application of scientific data in Chinese medicine. Strengthen the retrieval and utilization of scientific literature on Chinese medicine, promote the sharing of scientific data on Chinese medicine, support and cultivate the construction of scientific databases of Chinese medicine with international influence, provide support for the conduct of clinical trials of Chinese medicine, and use data to drive the tasks of clinical research, digital therapy research, intelligent drug screening and research and development of new Chinese medicines.

High-quality drugs are always the key to drug production. How to improve operational efficiency and reduce operating costs while ensuring the high quality of drugs is a question that every company must consider.

At present, companies such as Beijing Tong Ren Tang, Sichuan Taiji, and Tianjin Hongri can basically achieve full automation of workshop production.

At the same time, the application of new technologies and digitalization has also played a great role in reducing costs and increasing efficiency for enterprises.

Of course, these are not all the digital technologies that help Chinese medicine production.

Point 15 of the "Opinions" specifically emphasizes the improvement of the digitalization level of Chinese medicine production. Support the use of remote sensing, meteorological, soil and other data to create a digital and intelligent scene of Chinese medicine ecological planting supported by data and models, and enable Chinese medicine breeding, seedling cultivation and planting and breeding. Promote the construction and application of digital workshops, digital twin factories, smart logistics, smart warehouses, industrial Internet, etc., and improve the innovation ability and production efficiency of Chinese medicine companies.

At present, the country has basically established a product traceability system. Taking Chinese medicine as an example, drugs can be traced and queried from the planting base of medicinal materials to the final sales location of drugs, and even the patients who use them.

The application of these new technologies is actually a manifestation of digital applications.

The application of digitalization in the marketing link is actually more reflected in the management link.

The connection between the third and fourth phases of the Golden Tax has put forward higher requirements for the standardized operation of enterprises' products, ensuring price transparency and compliance with commercial policies, and establishing a clear industrial chain for enterprises in the marketing and production process of traditional Chinese medicine.

Point 15 of the "Opinion" talks about accelerating the digital drive of the entire industrial chain of traditional Chinese medicine, strengthening the construction and promotion of the platform of the quality traceability system of traditional Chinese medicine, and promoting the interconnection and rational use of data from the ecological environment, agricultural management, harvesting, processing, packaging, warehousing, maintenance, circulation and storage of traditional Chinese medicines to prescription circulation, prescription review, adjustment, distribution, clinical application and effect evaluation throughout the life cycle, empowering the quality management of traditional Chinese medicine products.

The research and development, production and marketing of traditional Chinese medicine complement each other. Research and development determines the core value of the product, production ensures product quality, and marketing is the key link for the product to reach the market smoothly. At the same time, marketing needs to be responsible for delivering value, building brands and promoting sales on the basis of compliance. The three jointly promote the market success and long-term development of pharmaceutical products.

https://mp.weixin.qq.com/